- Home
- RILY vs ENLV Comparison
RILY vs ENLV Comparison
Compare RILY & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.12
Company Overview
Basic Information| Metric | RILY | ENLV |
|---|---|---|
| Founded | 1973 | 2005 |
| Country | United States | Israel |
| Employees | 2056 | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.6M | 249.3M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | RILY | ENLV |
|---|---|---|
| Price | $7.74 | $1.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 574.1K | 217.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.99 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.67 | $0.66 |
| 52 Week High | $10.97 | $2.10 |
Technical Indicators
Market Signals| Indicator | RILY | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 56.12 | 52.51 |
| Support Level | $4.78 | $1.12 |
| Resistance Level | $10.97 | $1.23 |
| Average True Range (ATR) | 0.51 | 0.07 |
| MACD | 0.11 | -0.00 |
| Stochastic Oscillator | 84.26 | 52.00 |
Price Performance
Historical Comparison RILY
ENLV
About RILY B. Riley Financial Inc.
BRC Group Holdings Inc is a diversified holding company, including financial services, telecom, and retail, and investments in equity, debt and venture capital.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.